Greg Banker is a Partner at Vensana Capital. Greg brings over a decade of investing, operating, and consulting experience to Vensana. Prior to joining Vensana, Greg served as Director of Strategic Market Development at Vertiflex, an interventional spine medical device company that was acquired by Boston Scientific in 2019. Greg’s prior experience includes his work as an Associate Director at Navigant Consulting, where he advised medtech CEOs and boards of directors on over two dozen strategic market assessments across a range of sectors including cardiology, interventional pain, orthopedics, neurology, and robotic surgery. Greg currently serves on the board of directors of Artelon and Elucent Medical. He graduated with a BS in Biology from the University of Wisconsin – Madison.